The Global Dibenzoyl D-Tartaric Acid Monohydrate (CAS 17026-42-5) Market was valued at approximately USD 45.2 Million in 2023 and is projected to reach USD 67.8 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period (2024-2030). This growth is primarily driven by the escalating demand from the pharmaceutical industry for chiral resolution agents, increasing research and development activities in active pharmaceutical ingredients (APIs), and the expansion of asymmetric synthesis applications.

As the life sciences and fine chemicals sectors increasingly rely on high-purity chiral compounds, Dibenzoyl D-Tartaric Acid Monohydrate has emerged as a critical resolving agent. This blog profiles the Top 10 Companies in the Dibenzoyl D-Tartaric Acid Monohydrate Market—specialty chemical manufacturers and chiral technology pioneers shaping the future of enantiomer separation.

---

🔟 1. Changzhou Bestar

Headquarters: Changzhou, Jiangsu, China
Key Offering: High-Purity Dibenzoyl D-Tartaric Acid Monohydrate (≥99%), Custom Chiral Intermediates

Changzhou Bestar is a leading Chinese manufacturer of fine chemicals and pharmaceutical intermediates, with a strong focus on chiral compounds. The company has established itself as a key global supplier of Dibenzoyl D-Tartaric Acid Monohydrate, serving pharmaceutical clients worldwide with stringent quality standards.

Key Capabilities and Initiatives:

• Advanced purification technologies for high enantiomeric excess
• GMP-compliant manufacturing facilities
• Strong R&D focus on developing novel chiral resolution methodologies

Download FREE Sample Report: Dibenzoyl D-Tartaric Acid Monohydrate Market – View in Detailed Research Report

---

9️⃣ 2. Zephyr Synthesis Pvt. Ltd.

Headquarters: Hyderabad, Telangana, India
Key Offering: DBTA Monohydrate, Chiral Resolution Services, Custom Synthesis

Zephyr Synthesis specializes in the manufacturing of chiral compounds and pharmaceutical intermediates. The company has developed expertise in tartaric acid derivatives and serves both domestic and international markets with high-quality Dibenzoyl D-Tartaric Acid Monohydrate.

Key Capabilities and Initiatives:

• Integrated manufacturing from basic chemicals to advanced intermediates
• Strong quality control systems meeting international pharmacopeia standards
• Strategic focus on cost-effective production while maintaining high purity levels

---

8️⃣ 3. Shandong Wudi Kaisheng

Headquarters: Binzhou, Shandong, China
Key Offering: Industrial and Pharmaceutical Grade DBTA Monohydrate

Shandong Wudi Kaisheng is a chemical manufacturer with significant production capacity for tartaric acid derivatives. The company leverages China’s strong chemical manufacturing infrastructure to produce Dibenzoyl D-Tartaric Acid Monohydrate at competitive scales for global markets.

Key Capabilities and Initiatives:

• Large-scale production capabilities
• Competitive pricing strategy for bulk quantities
• Expanding international distribution networks

---

7️⃣ 4. Chengdu Likai Chiral Tech

Headquarters: Chengdu, Sichuan, China
Key Offering: High-Purity Chiral Compounds, DBTA Monohydrate, Resolution Kits

Chengdu Likai Chiral Technology specializes exclusively in chiral chemicals and separation technologies. The company has developed proprietary methodologies for producing high-purity Dibenzoyl D-Tartaric Acid Monohydrate and offers comprehensive chiral resolution solutions to pharmaceutical companies.

Key Capabilities and Initiatives:

• Specialization in chiral technology and enantiomer separation
• Development of novel chiral resolving agents
• Technical support and consultation services for chiral resolution projects

---

6️⃣ 5. Omkar Specialty Chemicals Limited

Headquarters: Mumbai, Maharashtra, India
Key Offering: Pharmaceutical Intermediates, Chiral Auxiliaries, DBTA Monohydrate

Omkar Specialty Chemicals is an established player in the fine chemicals sector with a diverse product portfolio that includes Dibenzoyl D-Tartaric Acid Monohydrate. The company serves pharmaceutical, agrochemical, and specialty chemical industries with a focus on quality and reliability.

Key Capabilities and Initiatives:

• Diversified chemical manufacturing expertise
• Strong regulatory compliance capabilities
• Strategic partnerships with global pharmaceutical companies

Download FREE Sample Report: Dibenzoyl D-Tartaric Acid Monohydrate Market – View in Detailed Research Report

---

5️⃣ 6. Toray Fine Chemicals

Headquarters: Tokyo, Japan
Key Offering: High-Purity Fine Chemicals, Chiral Resolution Agents, DBTA Derivatives

Toray Fine Chemicals, a subsidiary of the Toray Group, brings Japanese precision and quality to the chiral chemicals market. The company produces high-purity Dibenzoyl D-Tartaric Acid Monohydrate meeting the stringent requirements of the pharmaceutical industry, particularly in regulated markets.

Key Capabilities and Initiatives:

• Reputation for exceptional product quality and consistency
• Strong presence in highly regulated markets (Japan, US, EU)
• Continuous process optimization for enhanced purity and yield

---

4️⃣ 7. Alfa Aesar (Thermo Fisher Scientific)

Headquarters: Ward Hill, Massachusetts, USA
Key Offering: Laboratory Chemicals, Research-Grade DBTA Monohydrate

Alfa Aesar, part of Thermo Fisher Scientific, is a leading global supplier of research chemicals, metals, and materials. While not primarily a bulk manufacturer, the company is a crucial supplier of high-purity Dibenzoyl D-Tartaric Acid Monohydrate for research and development activities across academic and industrial laboratories.

Key Capabilities and Initiatives:

• Extensive global distribution network for research chemicals
• Multiple purity grades suitable for various research applications
• Strong brand recognition in the research community

---

3️⃣ 8. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: High-Purity Fine Chemicals, DBTA Monohydrate for Research

Tokyo Chemical Industry (TCI) is a global manufacturer and supplier of laboratory chemicals and fine chemicals. The company offers Dibenzoyl D-Tartaric Acid Monohydrate primarily for research purposes, serving pharmaceutical companies, universities, and research institutions worldwide.

Key Capabilities and Initiatives:

• Comprehensive catalog of fine chemicals and chiral compounds
• High standards of purity and quality control
• Strong customer support for research and development needs

---

2️⃣ 9. Santa Cruz Biotechnology

Headquarters: Dallas, Texas, USA
Key Offering: Biochemicals, Chiral Compounds, Research Chemicals

Santa Cruz Biotechnology is a supplier of biochemicals and research reagents, including chiral compounds like Dibenzoyl D-Tartaric Acid Monohydrate. The company serves the life sciences research community with high-quality chemicals for pharmaceutical development and academic research.

Key Capabilities and Initiatives:

• Focus on research-grade chemicals with documented purity
• Extensive product documentation and technical support
• Global distribution to research institutions and pharmaceutical companies

---

1️⃣ 10. BOC Sciences

Headquarters: Shirley, New York, USA
Key Offering: Fine Chemicals, Chiral Resolution Agents, Custom Synthesis

BOC Sciences is a chemical supplier and service provider offering a wide range of fine chemicals, including Dibenzoyl D-Tartaric Acid Monohydrate. The company combines manufacturing capabilities with sourcing expertise to serve pharmaceutical and biotechnology clients globally.

Key Capabilities and Initiatives:

• Integrated chemical sourcing and manufacturing model
• Custom synthesis capabilities for chiral compounds
• Quality assurance meeting pharmaceutical industry standards

Get Full Report Here: Dibenzoyl D-Tartaric Acid Monohydrate Market – View in Detailed Research Report

---

🔬 Outlook: The Future of Dibenzoyl D-Tartaric Acid Monohydrate Is Driven by Pharmaceutical Innovation

The Dibenzoyl D-Tartaric Acid Monohydrate market is experiencing steady growth as pharmaceutical companies increasingly prioritize chiral purity in drug development. The compound’s role as a versatile resolving agent positions it for continued relevance in asymmetric synthesis and enantiomer separation.

📈 Key Trends Shaping the Market:

• Growing emphasis on single-enantiomer drugs in pharmaceutical development
• Advancements in chiral separation technologies and methodologies
• Increasing regulatory requirements for chiral purity in pharmaceuticals
• Expansion of contract research and manufacturing services in Asia-Pacific

Get Full Report Here: Dibenzoyl D-Tartaric Acid Monohydrate Market – View in Detailed Research Report

The companies profiled above are not only supplying a critical chiral resolving agent—they’re enabling the development of safer, more effective pharmaceutical products through advanced enantiomer separation technologies.